MedTrace Logo

Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects

NCT04431908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1320

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.

Conditions

Interventions

DEVICE

olfactory device

A quantitative non-biased olfactory device intended for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR).

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • R Peter Manes, MD, FACS · Associate Professor of Surgery (Otolaryngology)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2020-10-15
Completion
2020-11-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431908 on ClinicalTrials.gov